AI trained on thousands of pancreatic cancer cases could revolutionize diagnosis
NCT ID NCT07713823
First seen Jul 20, 2026 · Last updated Jul 22, 2026 · Updated 2 times
Summary
This study collects and organizes data from 3,000 real pancreatic cancer patients, including those with early, advanced, and inoperable disease. Medical experts will label and structure the information to create a high-quality knowledge base. The goal is to train artificial intelligence to better understand and assist in diagnosing and treating pancreatic cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could create a powerful AI tool that helps doctors diagnose and treat pancreatic cancer more accurately by learning from thousands of real patient cases.
- What could go wrong
- This is an observational study that builds a database, not a treatment trial. The AI model may not perform as expected in real-world settings, and data quality depends on the completeness of medical records.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can High-Dose vitamin c boost Chemo's punch against pancreatic cancer?
- Can a cancer pill keep working outside the lab? a Real-World test begins
- Ancient acupressure meets modern medicine: can ear stimulation replace standard Anti-Nausea drugs?
- New oral drug targets Cancer's growth engine in advanced tumours
- New imaging compound targets Hard-to-Spot cancers
- Tailored nutrition after pancreatic surgery could speed recovery